TNFRSF17 and Miyoshi myopathy: We identified a population of MM cells resistant to anti-BCMA CAR-T therapy and demonstrated that attenuated effector function and elevated expression of immune checkpoint of T cells contribute to the relapse following anti-BCMA CAR-T therapy.